LEXX
Lexaria Bioscience Corp.
$0.90-0.05 (-5.26%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Lexaria Bioscience Corp. (LEXX) is a publicly traded company with 1 insider transaction disclosed via SEC Form 4 in the past 90 days, involving 1 unique insider. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 16 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-18 | 2026-03-17 | Bunka Christopher | Director | Gift | 100,000 | $0.00 | $0 | N/A | N/A |
| 2025-07-30 | 2025-07-30 | Bunka Christopher | Director | Purchase | 11,900 | $0.91 | $10,865 | -8.0% | -3.6% |
| 2025-07-30 | 2025-07-29 | Carle Vanessa | Secretary | Purchase | 750 | $0.91 | $683 | -3.3% | -2.2% |
| 2025-07-30 | 2025-07-29 | Christopher Richard | CEO | Purchase | 15,000 | $0.91 | $13,635 | -3.2% | -2.1% |
| 2025-07-30 | 2025-07-29 | Docherty John Martin | CSO | Purchase | 5,376 | $0.93 | $4,989 | -5.2% | -4.1% |
| 2025-07-30 | 2025-07-29 | Bunka Christopher | Director | Purchase | 15,600 | $0.92 | $14,383 | -4.6% | -3.5% |
| 2025-07-30 | 2025-07-29 | Mckechnie William Edward | Director | Purchase | 5,000 | $0.91 | $4,530 | -2.9% | -1.8% |
| 2025-05-16 | 2025-05-15 | Baxter Nicholas W | Director | Award | 11,000 | $0.00 | $0 | N/A | N/A |
| 2025-05-16 | 2025-05-15 | Reese Albert L Jr | Director | Award | 11,000 | $0.00 | $0 | N/A | N/A |
| 2025-05-16 | 2025-05-15 | Carle Vanessa | Secretary | Award | 15,000 | $0.00 | $0 | N/A | N/A |
LEXX
Director
Purchase
$4.5K
Mckechnie William Edward5,000 shares @ $0.91
Filed 2025-07-30Trade 2025-07-29
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.